SARS-CoV-2: a storm is raging

Cited by (1,000)

Items 301–400 of 1,000

1. Inflammatory profiles and clinical features of coronavirus 2019 survivors 3 months after discharge in Wuhan, China.
   Zhou, Mei, Yin, Zhengrong, Xu, Juanjuan, Wang, Sufei, Liao, Tingting, Wang, Kai, Li, Yumei, Yang, Fan, Wang, Zhen, Yang, Guanghai et al. · 2021 · The Journal of Infectious Diseases
2. Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019
   Jeremy R. DeGrado, Paul M. Szumita, Brian R. Schuler, Kevin M. Dube, Jesslyn Lenox, Edy Yong Kim, Gerald L. Weinhouse, Anthony F. Massaro · 2020 · Critical Care Explorations
3. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
   Vijay Kumar · 2020 · International Reviews of Immunology
4. Candesartan could ameliorate the COVID-19 cytokine storm
   ABDEL G. ELKAHLOUN, Juan M. Saavedra · 2020 · Biomedicine & Pharmacotherapy
5. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy
   Ruimin Hong, Houli Zhao, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, Guoqing Wei, He Huang · 2020 · Bone Marrow Transplantation
6. Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature
   Ariel Munitz, Liat Edry‐Botzer, Michal Itan, Ran Tur‐Kaspa, Dror Dicker, Dana Marcoviciu, Moran G. Goren, Michael Mor, Shir Lev, Tamar Gottesman et al. · 2021 · Scientific Reports
7. Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19
   Sara Velázquez, Rodrigo Madurga, Jose Maria Castellano, Jesús Rodríguez-Pascual, Santiago Ruiz de Aguiar Diaz Obregon, Sara Jimeno, Juan Ignacio Montero, Paula Sol Ventura, Alejandro López‐Escobar · 2021 · BMC Emergency Medicine
8. Novel Approach to Track the Lifecycle of Inflammation from Chemokine Expression to Inflammatory Proteins in Sweat Using Electrochemical Biosensor
   Badrinath Jagannath, Madhavi L Pali, Kai‐Chun Lin, Devangsingh Sankhala, Pejman Naraghi, Sriram Muthukumar, Shalini Prasad · 2022 · Advanced Materials Technologies
9. Hemogram as Marker of In-Hospital Mortality in Covid-19
   Alejandro López‐Escobar, Rodrigo Madurga, Jose Maria Castellano, Santiago Ruiz de Aguiar, Sara Velázquez, Marina Bucar, Sara Jimeno, Paula Sol Ventura · 2021 · Journal of Investigative Medicine
10. COVID-19 Immunobiology: Lessons Learned, New Questions Arise
    Aimilios Kaklamanos, Konstantinos Belogiannis, Panagiotis Skendros, Vassilis G. Gorgoulis, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas · 2021 · Frontiers in Immunology
11. Risk factors related to the severity of COVID-19 in Wuhan
    Zhao Chen, Yan Bai, Cencen Wang, Yanyan Zhong, Na Lu, Li Tian, Fucheng Cai, Runming Jin · 2020 · International Journal of Medical Sciences
12. Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience
    Massimiliano Ruscica, Chiara Macchi, Simona Iodice, Gregorio Tersalvi, Irene Rota, Simone Ghidini, Leonardo Terranova, Luca V. C. Valenti, Francesco Amati, Stefano Aliberti et al. · 2021 · European Journal of Clinical Investigation
13. Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
    Hoda Zarkoob, Anna Allué‐Guardia, Yu‐Chi Chen, Andreu Garcia‐Vilanova, Olive Jung, Steven L. Coon, Min Jae Song, Jun‐Gyu Park, Fatai S. Oladunni, Jesse Miller et al. · 2022 · Communications Biology
14. Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
    James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, Sirikalaya J. Brimson, Premrutai Thitilertdecha, Tewin Tencomnao · 2021 · Expert Opinion on Therapeutic Targets
15. Proteinuria and Clinical Outcomes in Hospitalized COVID-19 Patients
    Alexandre Karras, Marine Livrozet, Hélène Lazareth, Nicolas Bénichou, Jean‐Sébastien Hulot, Antoine Fayol, Sophie Chauvet, Anne‐Sophie Jannot, Marie-Aude Penet, Jean‐Luc Diehl et al. · 2021 · Clinical Journal of the American Society of Nephrology
16. Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?
    Mohammed S. Osman, Charmaine van Eeden, Jan Willem Cohen Tervaert · 2020 · Autoimmunity Reviews
17. COVID-19: the new challenge for rheumatologists. First update
    Francesco Ferro, Elena Elefante, Ilaria Puxeddu, Chiara Baldini, Elena Bartoloni, Claudia Baratè, Sara Galimberti, Rosaria Talarico, Marta Mosca, Stefano Bombardieri · 2020 · Clinical and Experimental Rheumatology
18. Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort
    Maroun E. Hayek, Michael Mansour, Harrison T. Ndetan, Quentin Burkes, Robert Corkern, Ammar Dulli, Reya Hayek, Karim Parvez, Satwinder Singh · 2021 · Mayo Clinic Proceedings Innovations Quality & Outcomes
19. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets
    Mohammad Mahdi Nejadi Babadaei, Anwarul Hasan, Samir Haj Bloukh, Zehra Edis, Majid Sharifi, Ehsan Kachooei, Mojtaba Falahati · 2020 · Journal of Biomolecular Structure and Dynamics
20. Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
    Rana Aljaberi, Kholoud Wishah · 2020 · Annals of Allergy Asthma & Immunology
21. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2
    Kinan Drak Alsibai · 2020 · Medical Hypotheses
22. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review
    Jorge Pérez, César Augusto Prócel Ramírez, Cristina Cañadas, Diana Aguirre, Ronny Pibaque, Ricardo Bedón-Galarza, Fernando Sempértegui, Hemmo A. Drexhage, Lucy Baldeón · 2021 · Vaccines
23. Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?
    Anna Kovalchuk, Bo Wang, Dongping Li, Rocio Rodriguez‐Juarez, Slava Ilnytskyy, Igor Kovalchuk, Olga Kovalchuk · 2021 · Aging
24. Hematological manifestations and complications of COVID-19
    Burak Erdinc, Sonu Sahni, Vladimir K. Gotlieb · 2021 · Advances in Clinical and Experimental Medicine
25. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking
    Yu Cai, Min Zeng, Yunzhong Chen · 2021 · Annals of Palliative Medicine
26. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia
    Fang Jia, Gang Wang, Jing Xu, Junhong Long, Fuxue Deng, Wei Jiang · 2021 · Aging
27. Program Intervensi Kembali Bersekolah Anak Usia Dini Masa Pandemi Covid-19
    Jhoni Warmansyah · 2020 · Jurnal Obsesi Jurnal Pendidikan Anak Usia Dini
28. Exosomes contribution in COVID-19 patients’ treatment
    Loubna Mazini, Luc Rochette, Gabriel Malka · 2021 · Journal of Translational Medicine
29. Numerical comparison of exhaled particle dispersion under different air distributions for winter heating
    Teng Li, Emmanuel Essah, Yuxin Wu, Yong Chun Cheng, Chunhui Liao · 2022 · Sustainable Cities and Society
30. Resistance of children to Covid-19. How?
    Alain Fischer · 2020 · Mucosal Immunology
31. Silent hypoxia: higher NO in red blood cells of COVID-19 patients
    Esmaeil Mortaz, Majid Malkmohammad, Hamidreza Jamaati, Parisa Adimi Naghan, Seyed Mohammadreza Hashemian, Payam Tabarsi, Maohammad Varahram, Hamidreza Zaheri, Efsun Gonca Uğur Chouseın, Gert Folkerts et al. · 2020 · BMC Pulmonary Medicine
32. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients
    Georg Lorenz, Philipp Moog, Quirin Bachmann, Paul Graf La Rosée, Heike Schneider, Michaela Schlegl, Christoph D. Spinner, Uwe W. Heemann, Roland Michael Schmid, Hana Algül et al. · 2020 · Scientific Reports
33. Measurement of Cellular Immune Response to Viral Infection and Vaccination
    Wilbert Bouwman, Wim Verhaegh, Laurent Holtzer, Anja van de Stolpe · 2020 · Frontiers in Immunology
34. Superinfections in COVID-19 Patients: Role of Antimicrobials
    Vijaya Lakshmi Nag, Navneet Kaur · 2021 · Dubai Medical Journal
35. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications
    Rajkumar Singh Kalra, Jaspreet Kaur Dhanjal, Avtar S. Meena, Vishal C. Kalel, Surya Dahiya, Birbal Singh, Saikat Dewanjee, Ramesh J. L. Kandimalla · 2021 · Frontiers in Aging Neuroscience
36. Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
    Allison Koenecke, Michael A. Powell, Ruoxuan Xiong, Zhu Shen, Nicole Mercado Fischer, Sakibul Huq, Adham M. Khalafallah, Marco Trevisan, Pär Sparén, Juan Jesús Carrero et al. · 2021 · eLife
37. The Potential Role of Extracellular Vesicles in COVID-19 Treatment: Opportunity and Challenge
    Yan‐yan Yan, Wen-min Zhou, Yu-qing Wang, Qiao-ru Guo, Fu-xi Zhao, Zhuang-yan Zhu, Yan-xia Xing, Hai-Yan Zhang, Mohamad Aljofan, Alireza Mosavi Jarrahi et al. · 2021 · Frontiers in Molecular Biosciences
38. Impact of Tai Chi on CRP, TNF-alpha and IL-6 in inflammation: a systematic review and meta-analysis
    Chenjie Shu, Shuo Feng, Qingyu Cui, Si-Fan Cheng, Yun Wang · 2021 · Annals of Palliative Medicine
39. Increased Kynurenine Indicates a Fatal Course of COVID-19
    Harald Mangge, Markus Herrmann, Andreas Meinitzer, Sabine Pailer, Pero Curcic, Zdenka Sloup, Magdalena Holter, Florian Prüller · 2021 · Antioxidants
40. On the Origin of Neutrophil Extracellular Traps in COVID-19
    Michal Pastorek, M Dúbrava, Peter Celec · 2022 · Frontiers in Immunology
41. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
    B. Escudero-Pérez, P. Lawrence, J. Castillo-Olivares · 2023 · Frontiers in Immunology
42. COVID-19: The Immune Responses and Clinical Therapy Candidates
    Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, Roozbeh Tarighati Rasekhi, Ghassem Rostamian, Mohamad Reza Kalani, Aida Rostamian, Jacob George, Mark W. Douglas · 2020 · International Journal of Molecular Sciences
43. The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)
    Subir Kumar Das · 2020 · Indian Journal of Clinical Biochemistry
44. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
    Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
45. A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
    Salima Daou, Manisha Talukdar, Jinle Tang, Beihua Dong, Shuvojit Banerjee, Yize Li, Nicole M. Duffy, Abiodun A. Ogunjimi, Christina Gaughan, Babal Kant Jha et al. · 2020 · Proceedings of the National Academy of Sciences
46. Immunomodulation for Severe COVID-19 Pneumonia: The State of the Art
    Yinhua Zhang, Yuanyuan Chen, Zhongji Meng · 2020 · Frontiers in Immunology
47. Targeting the renin−angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges
    K. Sriram, R. Loomba, P. Insel · 2020 · Proceedings of the National Academy of Sciences of the United States of America
48. COVID-19–associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron
    Antoine Bouquegneau, Pauline Erpicum, Stéphanie Grosch, Lionel Habran, Olivier Hougrand, Justine Huart, Jean-Marie Krzesinski, Benoît Misset, Marie‐Pierre Hayette, Philippe Delvenne et al. · 2021 · Kidney360
49. Repurposing Treatment of Wernicke–Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile
    Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, Vijay A. Ramchandani, Wenke Feng, Xiang Zhang, Craig James McClain · 2021 · Frontiers in Pharmacology
50. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
    Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani · 2021 · Immunologic Research
51. A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines
    Domenico Galati, Serena Zanotta, Ludovica Capitelli, Marialuisa Bocchino · 2021 · Allergy
52. Analysis of Host Immunological Response of Adenovirus-Based COVID-19 Vaccines
    Suzan Farhang‐Sardroodi, Chapin S. Korosec, Samaneh Gholami, Morgan Craig, Iain R. Moyles, Mohammad Sajjad Ghaemi, Hsu Kiang Ooi, Jane Marie Heffernan · 2021 · Vaccines
53. A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?
    Ayelén Rayen Toro, María Sol Ruiz, Sofía Lage-Vickers, Pablo Sanchis, Agustina Ayelen Sabater, Gastón Pascual, Rocio A. Seniuk, Florencia Cascardo, Sabrina Ledesma-Bazan, Felipe Vilicich et al. · 2022 · Antioxidants
54. Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
    Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, Shirou Matsumoto, Richard H. Kaszynski, Masaya Takemoto · 2022 · Pharmacology & Therapeutics
55. Hypothesis to explain the severe form of COVID-19 in Northern Italy
    Luca Cegolon, Jennifer Pichierri, Giuseppe Mastrangelo, Sandro Cinquetti, Giovanni Sotgiu, Saverio Bellizzi, Giuseppe Pichierri · 2020 · BMJ Global Health
56. Current Landscape of Imaging and the Potential Role for Artificial Intelligence in the Management of COVID-19
    Faiq Shaikh, Michael Brun Andersen, Muhammad Rizwan Sohail, Francisca Mulero, Omer Abdul Rehman Awan, Diana Roettger, Olga Kubassova, Jamshid Dehmeshki, Sotirios Bisdas · 2020 · Current Problems in Diagnostic Radiology
57. The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients
    Hengzhi Du, Dao Wen Wang, Chen Chen · 2020 · Journal of Cellular and Molecular Medicine
58. Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response
    Julie Demaret, Guillaume Lefèvre, Fanny Vuotto, Jacques Trauet, Alain Duhamel, Julien Labreuche, Pauline Varlet, Arnaud Dendooven, Sarah Stabler, Benoit Gachet et al. · 2020 · Clinical & Translational Immunology
59. Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19
    Fengtao Wei, Dexiao Kong, Tao Li, Ai Li, Yi Tan, Fang Jin-feng, Xianghua Zhuang, Chao Lai, Weihua Xu, Hong Dong et al. · 2021 · Clinics
60. COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
    Markus Friedrich Neurath · 2021 · Nature Reviews Gastroenterology & Hepatology
61. COVID-19 Infection Is Associated With New Onset Erectile Dysfunction: Insights From a National Registry
    Kevin Y. Chu, Sirpi Nackeeran, Laura Horodyski, Thomas A. Masterson, Ranjith Ramasamy · 2021 · Sexual Medicine
62. Human coronaviruses disassemble processing bodies
    Mariel Kleer, Rory P. Mulloy, Carolyn-Ann Robinson, Danyel Evseev, Maxwell P. Bui-Marinos, Elizabeth L. Castle, Arinjay Banerjee, Samira Mubareka, Karen Louise Mossman, Jennifer A. Corcoran · 2022 · PLoS Pathogens
63. Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation
    Annarita Mazzariol, Anna Benini, Ilaria Unali, Riccardo Nocini, Marcello Smania, Anna Bertoncelli, Francesco De Sanctis, Stefano Ugel, Katia Donadello, Enrico Polati et al. · 2021 · Frontiers in Cellular and Infection Microbiology
64. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
    Farzaneh Zahedipour, Fatemeh Zahedipour, Parvin Zamani, Mahmoud Reza Jaafari, Amirhossein Sahebkar · 2024 · Virus Research
65. Cardiovascular Diseases (CVDs) in COVID-19 Pandemic Era
    Vjekoslav Gerc, Izet Mašić, Nizama Salihefendić, Muharem Zildžić · 2020 · Materia Socio Medica
66. SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects
    Shiqin Li, Sijia Li, Cyrollah Disoma, Rong Zheng, Mei Ling Zhou, Aroona Razzaq, Pinjia Liu, Yuzheng Zhou, Zijun Dong, Ashuai Du et al. · 2020 · Reviews in Medical Virology
67. Cell‐mediated immunity to SARS‐CoV‐2
    Xiaolin Wang, Jingang Gui · 2020 · Pediatric Investigation
68. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still’s Disease: Similarities and Differences
    Jianfen Meng, Yuning Ma, Jinchao Jia, Mengyan Wang, Jialin Teng, Hui Shi, Honglei Liu, Yutong Su, Junna Ye, Yue Sun et al. · 2021 · Frontiers in Immunology
69. Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury
    Lele Wang, Jia‐Wei Yang, Jin‐Fu Xu · 2021 · Clinical Microbiology and Infection
70. COVID-19 infections in infants
    Małgorzata Sobolewska-Pilarczyk, Maria Pokorska‐Śpiewak, Anna Stachowiak, Magdalena Marczyńska, Ewa Talarek, Agnieszka Ołdakowska, Izabela Kucharek, Adam Jerzy Sybilski, Anna Mania, Magdalena Figlerowicz et al. · 2022 · Scientific Reports
71. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
    Elizabeth Delorme‐Axford, Daniel J. Klionsky · 2020 · Autophagy
72. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications
    Karel Smetana, Jan Brábek · 2020 · In Vivo
73. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
    Feng Gao, Kenneth I. Zheng, Huadong Yan, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, Yong-Ping Chen, G. Targher, C. Byrne, J. George et al. · 2021 · Frontiers in Endocrinology
74. Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection
    Safaa I. Tayel, Eman A. El-Masry, Gehan Ali Abdelaal, Somaia Shehab-Eldeen, Abdallah Said Essa, Nashwa Mahmoud Mouhamed Muharram · 2022 · International Journal of Biological Sciences
75. Dual Role of Exosome in Neurodegenerative Diseases: A Review Study
    Mohsen Sheykhhasan, Fatemeh Heidari, Mohsen Eslami Farsani, Maryam Azimzadeh, Naser Kalhor, Shima Ababzadeh, Reihaneh Seyedebrahimi · 2023 · Current Stem Cell Research & Therapy
76. Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review
    Marianne Riou, Florence Coste, Alain Meyer, Irina Enache, Samy Talha, Anne Charloux, Cyril Reboul, Bernard Gény · 2024 · International Journal of Molecular Sciences
77. Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
    Farha Naz, Mohd Arish · 2020 · Frontiers in Immunology
78. Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19
    Maria Laura Belladonna, Ciriana Orabona · 2020 · Frontiers in Pharmacology
79. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
    Daniela Dragonetti, Giuseppe Guarini, Michele Pizzuti · 2020 · Blood transfusion
80. Could Oral Phosphodiesterase 5 Inhibitors Have a Potential Adjuvant Role in Combating COVID-19 Infection?
    Taymour Mostafa · 2020 · Sexual Medicine Reviews
81. Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study
    Jie Fang, Hui Li, Wei Du, Ping Yu, Ying‐Yun Guan, Shi-Yu Ma, Dong Liu, Wei Chen, Guochao Shi, Xiao-Lan Bian · 2020 · Frontiers in Pharmacology
82. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment
    Hani Alothaid, Mohammed S. Aldughaim, Karim El Bakkouri, Sufana A. Al-Mashhadi, Ahmed Ali Al-Qahtani · 2020 · Channels
83. Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis
    Xijie Dong, Chuntao Wang, Xinghua Liu, Wei Gao, Xiangjun Bai, Zhanfei Li · 2020 · Frontiers in Immunology
84. Wide spectrum of clinical picture of COVID-19 in children — From mild to severe disease
    Anna Mania, Katarzyna Mazur‐Melewska, Karol Lubarski, Jadwiga Kuczma-Napierała, Justyna Mazurek, Katarzyna Jończyk‐Potoczna, Wojciech Służewski, Magdalena Figlerowicz · 2020 · Journal of Infection and Public Health
85. Histopathological features in fatal COVID-19 acute respiratory distress syndrome
    Hamid Merdji, Sylvain Mayeur, M. Schenck, Walid Oulehri, Raphaël Clère-Jehl, Sibylle Cunat, J.-É. Herbrecht, R. Janssen-Langenstein, Alina Nicolae, Julie Helms et al. · 2021 · Medicina Intensiva (English Edition)
86. The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-Analysis
    Farshad Heidari‐Beni, Amir Vahedian‐Azimi, Sajad Shojaei, Farshid Rahimi‐Bashar, Alireza Shahriary, Thomas P. Johnston, Amirhossein Sahebkar · 2021 · Advances in experimental medicine and biology
87. COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon
    Hans Carl Hasselbalch, Vibe Skov, Lasse Kjær, Christina Ellervik, A. Poulsen, Troels Dirch Poulsen, Claus Henrik Nielsen · 2021 · Cytokine & Growth Factor Reviews
88. Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study
    Caterina Conte, Antonio Esposito, Rebecca DE LORENZO, Luigi di Filippo, Anna Palmisano, Davide Vignale, Riccardo Leone, Valeria Nicoletti, Annalisa Ruggeri, Guglielmo Gallone et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
89. Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19
    Yanghong Ni, Aqu Alu, Lei Hong, Yang Wang, Min Wu, Xiawei Wei · 2021 · Molecular Biomedicine
90. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence
    F. Idalsoaga, G. Ayares, J. Arab, L. Díaz · 2021 · Journal of Clinical and Translational Hepatology
91. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2
    So Yeong Cheon, Bon‐Nyeo Koo · 2021 · International Journal of Molecular Sciences
92. Impact of COVID-19 Infection on Quality of Sleep
    Ayesha A. Choudhry, Fnu Shahzeen, Sara A Choudhry, Narjis Batool, Fatir Murtaza, Anum Dilip, Murk Rani, Aakash Chandnani · 2021 · Cureus
93. Two-dimensional material-based virus detection
    Wenbin Wang, Wei Zhai, Ye Chen, Qiyuan He, Hua Zhang · 2022 · Science China Chemistry
94. The intriguing features of COVID‐19 in children and its impact on the pandemic
    Marco Aurélio Palazzi Sáfadi · 2020 · Jornal de Pediatria (Versão em Português)
95. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
    Jiaying Shen, Junyan Fan, Yue Zhao, Doming Jiang, Zheyun Niu, Zihan Zhang, Guangwen Cao · 2023 · Frontiers in Immunology
96. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
    Prakash S. Nagarkatti, Kathryn Miranda, Mitzi Nagarkatti · 2020 · Frontiers in Pharmacology
97. Potential Nutraceuticals for COVID-19
    Sayali Savant, Shraddha Srinivasan, Anil Kumar Kruthiventi · 2021 · Nutrition and Dietary Supplements
98. Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients
    Qigao Chen, Baodan Yu, Yihao Yang, Jiewen Huang, Ying Liang, Jing Zhou, Lianzhong Li, Xuechun Peng, Bolin Cheng, Yongping Lin · 2021 · International Immunopharmacology
99. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside
    Elham Bidram, Yasaman Esmaeili, Abbas Amini, Rossella Sartorius, Franklin R. Tay, Laleh Shariati, Pooyan Makvandi · 2021 · ACS Biomaterials Science & Engineering
100. Severe COVID-19 Is Characterised by Perturbations in Plasma Amines Correlated with Immune Response Markers, and Linked to Inflammation and Oxidative Stress
     Naama Karu, Alida S. D. Kindt, Adriaan J. van Gammeren, Anton A. M. Ermens, Amy C. Harms, Lützen Portengen, Roel C.H. Vermeulen, Willem A. Dik, Anton W. Langerak, Vincent H. J. van der Velden et al. · 2022 · Metabolites